eltrombopag

Generic: eltrombopag

Labeler: xlcare pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name eltrombopag
Generic Name eltrombopag
Labeler xlcare pharmaceuticals inc.
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

eltrombopag olamine 50 mg/1

Manufacturer
XLCare Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 72865-301
Product ID 72865-301_3bc65bc5-9a03-0ece-e063-6394a90a0a7c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA206788
Listing Expiration 2026-12-31
Marketing Start 2025-08-07

Pharmacologic Class

Classes
breast cancer resistance protein inhibitors [moa] increased megakaryocyte maturation [pe] increased platelet production [pe] organic anion transporting polypeptide 1b1 inhibitors [moa] thrombopoietin receptor agonist [epc] thrombopoietin receptor agonists [moa] ugt1a1 inhibitors [moa] ugt1a3 inhibitors [moa] ugt1a4 inhibitors [moa] ugt1a6 inhibitors [moa] ugt1a9 inhibitors [moa] ugt2b15 inhibitors [moa] ugt2b7 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72865301
Hyphenated Format 72865-301

Supplemental Identifiers

RxCUI
825421 825427 884617 1245001
UPC
0372865299302 0372865300305 0372865302309
UNII
4U07F515LG

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name eltrombopag (source: ndc)
Generic Name eltrombopag (source: ndc)
Application Number ANDA206788 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 14 TABLET, FILM COATED in 1 BOTTLE (72865-301-14)
  • 30 TABLET, FILM COATED in 1 BOTTLE (72865-301-30)
source: ndc

Packages (2)

72865-301-14 14 TABLET, FILM COATED in 1 BOTTLE (72865-301-14) 72865-301-30 30 TABLET, FILM COATED in 1 BOTTLE (72865-301-30)

Ingredients (1)

eltrombopag olamine (50 mg/1)

Linked Drug Pages (1)

ELTROMBOPAG ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3bc65bc5-9a03-0ece-e063-6394a90a0a7c", "openfda": {"upc": ["0372865299302", "0372865300305", "0372865302309"], "unii": ["4U07F515LG"], "rxcui": ["825421", "825427", "884617", "1245001"], "spl_set_id": ["9af1e314-91ca-4ebc-ac12-f9fddc6d7902"], "manufacturer_name": ["XLCare Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "14 TABLET, FILM COATED in 1 BOTTLE (72865-301-14)", "package_ndc": "72865-301-14", "marketing_start_date": "20250807"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (72865-301-30)", "package_ndc": "72865-301-30", "marketing_start_date": "20250807"}], "brand_name": "ELTROMBOPAG", "product_id": "72865-301_3bc65bc5-9a03-0ece-e063-6394a90a0a7c", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Increased Megakaryocyte Maturation [PE]", "Increased Platelet Production [PE]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Thrombopoietin Receptor Agonist [EPC]", "Thrombopoietin Receptor Agonists [MoA]", "UGT1A1 Inhibitors [MoA]", "UGT1A3 Inhibitors [MoA]", "UGT1A4 Inhibitors [MoA]", "UGT1A6 Inhibitors [MoA]", "UGT1A9 Inhibitors [MoA]", "UGT2B15 Inhibitors [MoA]", "UGT2B7 Inhibitors [MoA]"], "product_ndc": "72865-301", "generic_name": "ELTROMBOPAG", "labeler_name": "XLCare Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ELTROMBOPAG", "active_ingredients": [{"name": "ELTROMBOPAG OLAMINE", "strength": "50 mg/1"}], "application_number": "ANDA206788", "marketing_category": "ANDA", "marketing_start_date": "20250807", "listing_expiration_date": "20261231"}